CHEMIPHAR'S THREE BUSINESS AREAS
- - Develop a distinctive generic drug business that pursues quality.
- - Expand business by developing innovative products based on core technologies cultivated in the field of allergy.
- - Continuously develop and monetize groundbreaking new drugs based on our proprietary technologies and know-how, including alkalization therapy.
- Realize a global presence by aggressively developing our three areas of business abroad.
The goal of the Chemiphar Group is to make a difference in society by providing pharmaceutical drugs and health-related services to help people become and remain healthy.
October 31, 2024 | Summary of consolidated financial results for the Second quarter of FY2024. (pdf, 186KB) |
---|---|
October 31, 2024 | |
August 30, 2024 | |
July 31, 2024 | Summary of consolidated financial results for the first quarter of FY2024. (pdf, 173KB) |
July 31, 2024 | |
June 29, 2024 | Notice of the 92nd Ordinary General Meeting of Shareholders. (PDF, 375KB) |
May 13, 2024 | Summary of Consolidated Financial Results for the Fiscal Year 2023. (pdf, 204KB) |
---|---|
May 13, 2024 | |
May 07, 2024 | |
January 31, 2024 | Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2023. (pdf, 152KB) |